Quality of life of children with atopic dermatitis and their families
The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Abstract
PURPOSE OF THE REVIEW: Over the last few years major advances have been made in the conceptualization of quality of life and new instruments have been developed for assessing the construct in paediatric atopic dermatitis. This review looks at these developments and reports on recently published articles on the impact of the condition on affected children and other members of their family. RECENT FINDINGS: During the period of the review only one article addressing the impact of treatment for paediatric atopic dermatitis on quality of life could be found. This showed the benefits to the quality of life of parents of treating their children with pimecrolimus cream. SUMMARY: Given the prevalence of paediatric atopic dermatitis and its impact on affected children and their families it is surprising that so little attention has been devoted to the impact of treatment on quality of life. Where standardized measures are included in studies they generally assess outcomes that are of interest to physicians rather than to patients and their carers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The disorder results in significant morbidity and adversely affects quality of life [2].”
From Atopic dermatitis (2018) · cites this paper as [2]
In the citing paper
“Regardless of age, the itching associated with AD generally continues throughout the day and worsens at night, leading to sleep loss and substantial impairments in quality of life [2, 9].”
From Atopic dermatitis (2018) · cites this paper as [2]
Citations
Cites
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use
LEWIS-JONES, M. S., & FINLAY, A. Y. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb16953.x · Cited by 1,051
The family impact of childhood atopic dermatitis: The Dermatitis Family Impact Questionnaire
Lawson, Lewis-Jones, Finlay, Reid, & Owens (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02034.x · Cited by 434
The Infants’ Dermatitis Quality of Life Index
Lewis-Jones, M. S., Finlay, A. Y., & Dykes, P. J. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.03960.x · Cited by 384
Grimalt, R., Mengeaud, V., & Cambazard, F. (2007) · Dermatology · doi:10.1159/000096915 · Cited by 245
Psychosocial adjustment in preschool children with atopic eczema.
Daud, L. R., Garralda, M. E., & David, T. J. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.69.6.670 · Cited by 202
Defining Patient-Reported Outcomes
Doward, L. C., & McKenna, S. P. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.7s102.x · Cited by 193
Self-citationFölster-Holst, R., Müller, F., Schnopp, N., Abeck, D., Kreiselmaier, I., Lenz, T., Von Rüden, U., Schrezenmeir, J., Christophers, E., & Weichenthal, M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07558.x · Cited by 166
Psychosocial Aspects of Disease
LIPOWSKI, Z. J. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-6-1197 · Cited by 124
Ricci, G., Bendandi, B., Bellini, F., Patrizi, A., & Masi, M. (2007) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2006.00502.x · Cited by 120
Beattie, P. E., & Lewis-Jones, M. S. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07525.x · Cited by 115
Research works printed but not linked: 3
- Finlay, 1992, Quality of life impairment in atopic dermatitis and psoriasis, Clinical and Experimental Perspectives in Sandimmun Therapy, 2, 10
- Von Rueden, 1999, Development and validation of a disease specific questionnaire on quality of life of parents of children with atopic dermatitis, Z F Gesundheitswiss, 4, 335
- McKenna, 2006, Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): Impact on quality of life and health-related quality of life, JEADV, 20, 248
Cited by
Thaçi, D., Simpson, E. L., Beck, L. A., Bieber, T., Blauvelt, A., Papp, K., Soong, W., Worm, M., Szepietowski, J. C., Sofen, H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00388-8 · Cited by 572
Hamilton, J. D., Suárez-Fariñas, M., Dhingra, N., Cardinale, I., Li, X., Kostic, A., Ming, J. E., Radin, A. R., Krueger, J. G., Graham, N., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.013 · Cited by 469
Simpson, E. L., Bieber, T., Eckert, L., Wu, R., Ardeleanu, M., Graham, N. M. H., Pirozzi, G., & Mastey, V. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.10.043 · Cited by 302
Dupilumab for treatment of atopic dermatitis
Seegräber, M., Srour, J., Walter, A., Knop, M., & Wollenberg, A. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1449642 · Cited by 222
“Atopic dermatitis affects the life quality of patients tremendously, especially in more severe cases [8,9].”
BackgroundKapur, S., Watson, W., & Carr, S. (2018) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-018-0281-6 · Cited by 175
“The disorder results in significant morbidity and adversely affects quality of life [2].”
BackgroundRehal, B., & Armstrong, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017520 · Cited by 167
“Despite continuing efforts in developing new treatments for atopic dermatitis, scarce literature exists that evaluates disease-severity and quality-of-life (QoL) outcome measures in AD [4,5,6,7].”
BackgroundIlves, M., Palomäki, J., Vippola, M., Lehto, M., Savolainen, K., Savinko, T., & Alenius, H. T. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0038-4 · Cited by 156
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial
Sigurgeirsson, B., Boznanski, A., Todd, G., Vertruyen, A., Schuttelaar, M.-L. A., Zhu, X., Schauer, U., Qaqundah, P., Poulin, Y., Kristjansson, S., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-1990 · Cited by 149
Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
Ou, Z., Chen, C., Chen, A., Yao, Y., & Zhou, W. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.11.031 · Cited by 143
Whiteley, J., Emir, B., Seitzman, R., & Makinson, G. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1195733 · Cited by 132
The Impact of Atopic Dermatitis on Quality of Life
Lifschitz, C. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370226 · Cited by 127
Watson, W., & Kapur, S. (2011) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-7-s1-s4 · Cited by 114
“The disorder results in significant morbidity and adversely affects quality of life [2].”
Quality of Life and Disease Impact of Atopic Dermatitis and Psoriasis on Children and Their Families
Na, C. H., Chung, J., & Simpson, E. L. (2019) · Children · doi:10.3390/children6120133 · Cited by 137
Armstrong, A. W., Johnson, M. A., Lin, S., Maverakis, E., Fazel, N., & Liu, F.-T. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.2299 · Cited by 90
Favrot, C., Линек, М., Mueller, R. S., Zini, E., & for the International Task Force on Canine Atopic Dermatitis (2010) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2009.00781.x · Cited by 87
Eberlin, S., Silva, M. S. D., Facchini, G., Silva, G. H. D., Pinheiro, A. L. T. A., Eberlin, S., & Pinheiro, A. D. S. (2020) · Alternatives to Laboratory Animals · doi:10.1177/0261192920914193 · Cited by 69
“AD is a highly pruritic chronic inflammatory skin disorder that most commonly affects children, resulting in significant morbidity and an adverse effect on the quality of life.(35,36) AD treatment requires the frequent application of emollients to soften and moisturise the skin, in addition to various types of topical…”
BackgroundAugustin, M., Langenbruch, A. K., Blome, C., Gutknecht, M., Werfel, T., Ständer, S., Steinke, S., Kirsten, N., Silva, N. T., & Sommer, R. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15919 · Cited by 65
Langenbruch, A., Radtke, M., Franzke, N., Ring, J., Foelster‐Holst, R., & Augustin, M. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12154 · Cited by 60
Mesenchymal Stem Cells and Atopic Dermatitis: A Review
Daltro, S. R. T., Meira, C. S., Santos, I. P., dos Santos, R. R., & Soares, M. B. P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00326 · Cited by 58
“In adulthood, the predominant areas of eczema are the flexural folds, the face and neck, the upper arms and back, hands, feet, fingers and toes (McKenna and Doward, 2008; Weidinger and Novak, 2016; Kapur et al., 2018).”
BackgroundChow, M. Y. K., Morrow, A., Robbins, S. C. C., & Leask, J. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0343-z · Cited by 55
“Aspects such as personality, economic status, day-today functioning, spiritual status, environment, culture and life satisfaction are often considered when measuring QoL [23, 24].”
BackgroundNutritional Factors in the Prevention of Atopic Dermatitis in Children
Trikamjee, T., Comberiati, P., D’Auria, E., Peroni, D. G., & Zuccotti, G. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.577413 · Cited by 65
“Atopic dermatitis (AD) is a common inflammatory skin disease, which affects as many as one-fifth of all individuals (1) and is associated with a high financial and psychosocial burden for patients and their families (2, 3).”
BackgroundBarrier-Restoring Therapies in Atopic Dermatitis: Current Approaches and Future Perspectives
Valdman‐Grinshpoun, Y., Ben‐Amitai, D., & Zvulunov, A. (2012) · Dermatology Research and Practice · doi:10.1155/2012/923134 · Cited by 54
“The disease has significant morbidity and it adversely affects the quality-of-life of the child and his family in both social and emotional aspects [2].”
BackgroundReview of Systemic Treatment Options for Adult Atopic Dermatitis
Gooderham, M., Lynde, C. W., Papp, K. A., Bourcier, M., Guenther, L., Gulliver, W. P. F., Hong, C.-H., Poulin, Y. P., Sussman, G. L., & Vender, R. B. (2016) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475416670364 · Cited by 48
“AD is associated with significant morbidity as well as physical, psychological, and economical QOL impairment.(4,10-24) Intense pruritus frequently leads to significant sleep disturbances as well as irritability and reduced performance at school and work in both those affected with AD and their caregivers.”
BackgroundPatient-reported outcomes and quality of life measures in atopic dermatitis
Vakharia, P. P., Cella, D. F., & Silverberg, J. I. (2018) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2018.05.011 · Cited by 48
Wrześniewska, M., Wołoszczak, J., Świrkosz, G., Szyller, H. P., & Gomułka, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126539 · Cited by 59
“Itchiness, a hallmark of eczema, persists throughout the day and often intensifies at night, resulting in sleep disturbances and significant declines in quality of life regardless of age [6,7].”
BackgroundGrant, L., Larsen, L. S., Trennery, C., Silverberg, J. I., Abramovits, W., Simpson, E. L., Stalder, J.-F., Paty, J. A., Hahn-Pedersen, J. H., Kragh, N., et al. (2019) · Dermatitis · doi:10.1097/der.0000000000000486 · Cited by 43
Trzeciak, M., Gleń, J., Bandurski, T., Sokołowska‐Wojdyło, M., Wilkowska, A., & Roszkiewicz, J. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2011.04113.x · Cited by 42
Luger, T. A., Raeve, L. E. D., Gelmetti, C. M., Kakourou, T., Κατσαρού, Α., Lambert, J. R., Morren, M., Oranje, A. P., Ruer, M., Serdaroğlu, S., et al. (2013) · European Journal of Dermatology · doi:10.1684/ejd.2013.2169 · Cited by 45
“The disease has a considerable impact on the uality of life (QoL) of both patients and their families [6].”
BackgroundHeinl, D., Chalmers, J. R., Nankervis, H., & Apfelbacher, C. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2322 · Cited by 37
“Even though the QoL of patients and their family is greatly impacted by eczema, respective outcome measures often seem to only play a minor part in eczema trials (99).”
BackgroundResource Utilization and Quality of Life Associated with Congenital Ichthyoses
Kamalpour, L., Gammon, B., Chen, K., Veledar, E., Pavlis, M., Rice, Z. P., & Chen, S. C. (2011) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2011.01432.x · Cited by 33
Kornmehl, H. A., Singh, S., Johnson, M. A., & Armstrong, A. W. (2017) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2016.0249 · Cited by 32
“9 Research has suggested telemedicine as a potential solution for the physician shortage.”
The use of dupilumab in severe atopic dermatitis during pregnancy: a case report
Akhtar, N. H., Khosravi‐Hafshejani, T., Akhtar, D. H., Dhadwal, G., & Kanani, A. S. (2022) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-022-00650-w · Cited by 28
Extended implementation of educational programs for atopic dermatitis in childhood
Ahrens, B., & Staab, D. (2015) · Pediatric Allergy and Immunology · doi:10.1111/pai.12358 · Cited by 26
“Quality of life of children with AD and their families is reduced by interrupted sleep, itching skin conditions, and a stigmatizing appearance but also the fear of recurring (super)infections and possible hospitalization (16, 17).”
BackgroundZhao, J., Chen, Z., & Li, L. (2019) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2018.0276 · Cited by 21
“AD greatly inflicts patients and affects their health-related quality of life adversely, both physically and physiologically (McKenna and Doward, 2008).”
van Oosterhout, M., Janmohamed, S. R., Spierings, M., Hiddinga, J., der Spek, F. B. D. W., & Oranje, A. P. (2015) · Dermatology · doi:10.1159/000367689 · Cited by 19
The ABCs of Skin Care for Wound Care Clinicians
Woo, K. Y., & Sibbald, R. G. (2009) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000350837.17691.7f · Cited by 16
“Often described as distressing, itch, along with disfiguring skin lesions, can have a tremendous impact on the person’s mental well-being and emotional development.(9) The exact pathophysiology in AD remains elusive, but may be mediated by excessive production and activities of T cells, antigen-presenting cells (eg, L…”
BackgroundRehal, B., & Armstrong, A. W. (2011) · PLoS ONE · doi:10.1371/annotation/6d5e99c5-bd8f-4cef-b77a-fbb795633da0 · Cited by 14
Kritsanaviparkporn, C., Sangaphunchai, P., & Treesirichod, A. (2021) · Indian Journal of Dermatology Venereology and Leprology · doi:10.25259/ijdvl_1384_20 · Cited by 14
Carr, S., Pratt, R., White, F., & Watson, W. T. A. (2024) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-024-00927-2 · Cited by 23
“The disorder results in significant morbidity and adversely affects quality of life (QoL) [2].”
The emerging role of the neuroimmune cytokine interleukin-31 in chronic inflammatory skin diseases
GIROLOMONI, G., MAURELLI, M., & GISONDI, P. (2022) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.22.07265-6 · Cited by 12
Impact of Atopic Dermatitis® on Quality of Life of Caregivers: A Systematic Review and Meta-Analysis
Yap, J. C. H., & Yew, Y. W. (2024) · Dermatitis · doi:10.1089/derm.2023.0362 · Cited by 13
Basal serum cortisol and adrenocorticotropic hormone levels in patients with atopic dermatitis
Tehranchinia, Z., Rahimi, H., & Lofti, S. (2017) · Dermatology Practical & Conceptual · doi:10.5826/dpc.0704a07 · Cited by 10
“Unpredictable course, chronic and relapsing nature of the disease and disturbing pruritus can impose extensive psychological and emotional burden to patients with AD and their families [8-11].”
BackgroundMarinello, E., Linder, D., Spoto, A., Palmer, K., Rohrer, P. M., Büchi, S., Trapp, M., Trapp, E.-M., Hörlesberger, N., Piaserico, S., et al. (2016) · Dermatology · doi:10.1159/000448030 · Cited by 8
Jariwala, N. N., Snider, C. K., Mehta, S. J., Armstrong, J. K., Smith–McLallen, A., Takeshita, J., Kovarik, C., & Lipoff, J. B. (2020) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2020.0248 · Cited by 9
Health Outcomes in Atopic Dermatitis
Rehal, B., & Armstrong, A. W. (2011) · Dermatologic Clinics · doi:10.1016/j.det.2011.08.007 · Cited by 9
Patients’ and caregivers’ perspectives of the atopic dermatitis journey
Feldman, S. R., Chan, A. W. M., Ammoury, A., Zhang, J., Tanaka, A., Shi, X., Cha, A., & Tran, H. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2024.2315145 · Cited by 7
“…studies, patients with AD and caregivers of patients with AD have expressed that they must play a more active role in communicating the physical and emotional impact of AD and that there needs to be greater emphasis on shared decision-making when considering potential treatment options (18,19).”
Fong, W. C. G., Kaung, H. H. W., Lopes, R., Kanji, A., Ravenscroft, J., Tang, T. S., & Flohr, C. (2024) · Pediatric Dermatology · doi:10.1111/pde.15761 · Cited by 6
Bagdi, N., & Ram, H. (2020) · International Journal of Homoeopathic Sciences · doi:10.33545/26164485.2020.v4.i2a.150 · Cited by 6
Tratamiento de la dermatitis atópica
Cudós, E. S., & Laguna, R. D. L. (2009) · Pediatría Atención Primaria · doi:10.4321/s1139-76322009000300004 · Cited by 5
The effect of atopic dermatitis on quality of life of affected dogs and their owners in Romania
Florea, T., Dărăbuş, G., Mederle, N. G., Sîrbu, C. B., Imre, M., & Morariu, S. (2021) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2021.07.006 · Cited by 9
Alradaddi, A., Twaim, A. A., Abualiat, A., Al-Atass, K., Alogayell, L., Aldayil, M., Al-Breiki, S., Abed, S. S., Fatani, M. I. A., Alsharif, O., et al. (2022) · Dermatology Research and Practice · doi:10.1155/2022/5636903 · Cited by 6
Stamatas, G. N., Zvulunov, A., Horowitz, P., & Grove, G. L. (2012) · Dermatology Research and Practice · doi:10.1155/2012/691954 · Cited by 3
Basal Serum Cortisol and Adrenocorticotropic Hormone Levels in Patients with Atopic Dermatitis
Tehranchinia, Z., & Rahimi, H. (2016) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.1000236 · Cited by 1
Kelbore, A. G., Enbiale, W., Mosam, A., & Wyk, J. V. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02133-w · Cited by 2
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
do Amaral, C. S. F., March, M. D. F. B. P., & Sant’Anna, C. C. (2013) · Clinical Investigation · doi:10.4155/cli.13.88 · Cited by 2
Use of Moisturizers in Patients with Atopic Dermatitis
Hon, K. E., & Leung, A. K. C. (2012) · Springer eBooks · doi:10.1007/978-3-642-27606-4_5 · Cited by 2
Yoon, S., Jeong, Y. C., Choi, J. H., Baek, H., Oh, J., Ahn, D.-H., & Lee, H.-B. (2011) · Pediatric Allergy and Respiratory Disease · doi:10.7581/pard.2011.21.4.285 · Cited by 2
Kim, Y.-H., Kim, J., Han, J.-M., Lee, H.-Y., Jung, I. C., Jin, M., Kim, S.-H., & Park, Y.-C. (2014) · The Journal of Internal Korean Medicine · Cited by 2
Peripheral natural killer cell subsets in atopic dermatitis
Mourad, B. H., Abdelnabi, N., Elgarhy, L. H., & Attia, M. A. (2015) · Journal of the Egyptian Womenʼs Dermatologic Society · doi:10.1097/01.ewx.0000455631.30660.32 · Cited by 2
Atopic dermatitis in children. A current algorithm for the disease treatment and control
Proshutinskaya, D. V. (2016) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2016-92-2-65-70 · Cited by 2
Zaslavsky, D. V. (2015) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2015-91-4-119-125 · Cited by 1
Abraham, A., Ganjoo, A., Kapoor, S., Sharma, D., & Talathi, A. (2021) · International Journal of Research in Dermatology · doi:10.18203/issn.2455-4529.intjresdermatol20213341 · Cited by 1
“AD significantly impairs the quality of life in children and their family.(4) Intense pruritus as well as sleep disturbance are the major symptoms experienced by children suffering from AD.”
BackgroundGanjoo, A., Shah, S., Godse, K. V., Porwal, S., Caplash, P., Pereira, R., Nair, R., & Korukonda, K. (2023) · International Journal of Research in Dermatology · doi:10.18203/issn.2455-4529.intjresdermatol20233180 · Cited by 1
Comorbidity, distress, coping and social support in asthma and allergy
Lind, N. (2015) · DiVA at Umeå University (Umeå University) · Cited by 2
Carolina, A. I. (2013) · Revista Med · doi:10.18359/rmed.1181
“La ansiedad y la depresión son algunos de los trastornos, más frecuentemente relacionados con la DA (10-18).”
BackgroundAcupuntura en dermatitis atópica y mecanismos neuroinmumonológicos. Actualización
Robayo, M. P., Mauricio Ángel, M., & M., C. L. R. (2011) · Revista Med · doi:10.18359/rmed.1210
Santos, A. F., Fox, A. T., Toit, G. D., & Lack, G. (2009)
SKIN MICROBIOTA AND ATOPIC DERMATITIS IN CHILDREN: NEW TREATMENT OPTIONS
Smirnova, G. I., Munblit, D., Kolotilina, A., & Levina, D. (2019) · Russian Pediatric Journal · doi:10.18821/1560-9561-2018-21-2-106-113
The Use of Dupilumab in Atopic Dermatitis During Coronavirus Disease-19 Era – A Review
Kosasih, L. P. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.5359
“Literature shows that AD is significantly affecting all aspects of the quality of life of patients and their families [11], [18], [19] (Figures 1 and 2).”
BackgroundТехнологическая схема и особенности регулирования производительности шахтной вентиляторной установки
Нгуен, М. Т. (2014) · Известия Тульского государственного университета. Технические науки
Zanke, A. A., Gangurde, H. H., Ghonge, A. B., & Hiwale, P. R. (2021) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2021.011
“/ IP International Journal of Comprehensive and Advanced Pharmacology 2021;6(2):63–70 67”
BackgroundInfluentialAtopik dermatit tanılı çocukların aile bireylerinde yaşam ve uyku kalitesinin değerlendirilmesi
SARİ, S., Geçkalan, D., & Türkeli, A. (2022) · Pamukkale Medical Journal · doi:10.31362/patd.1031195
Люгер, Т., Raeve, L. E. D., Гельметти, К., Какуру, Т., Катсару, А., Lambert, D., Morren, M. A., Оранье, А., Рюэр, М., Serdaroğlu, S., et al. (2020) · Педиатрия Восточная Европа · doi:10.34883/pi.2020.8.1.012
Садыкова, Д. А., Юсупова, Д. М., & Талантбек, К. А. (2024) · Nauka, novye tehnologii i innovacii Kyrgyzstana. · doi:10.26104/nntik.2023.21.61.027
Metadata
- Authors
- McKenna, S. P., & Doward, L. C.
- Affiliations
- University of Lancashire (GB)
- Corresponding author
- McKenna, Stephen P
- Venue
- Current Opinion in Allergy & Clinical Immunology
- Published
- 2008-06
- Volume
- 8
- Issue
- 3
- Pages
- 228-231
- ISSN
- 1473-6322 (ISSN-L)
- 1528-4050
- OpenAlex
- W2092702041
- Cited by
- 74
- References
- 22
- Citations by year
- 2024: 6 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 3
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- pediatric atopic dermatitis, quality of life, children, family, quality of life instruments, pimecrolimus, treatment effects, patient-reported outcomes
- MeSH terms
- Child, Clinical Trials as Topic, Dermatitis, Atopic, Family, Health Status, Health Status Indicators, Humans, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Treatment Outcome, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.